🇺🇸 FDA
Pipeline program

Bacteriophage Therapy

APT.DFI.001

Phase 2 mab terminated

Quick answer

Bacteriophage Therapy for Osteomyelitis is a Phase 2 program (mab) at Adaptive Biotechnologies Corp with 1 ClinicalTrials.gov record(s).

Program details

Company
Adaptive Biotechnologies Corp
Indication
Osteomyelitis
Phase
Phase 2
Modality
mab
Status
terminated

Clinical trials